Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study-Reference-Cited by-同舟云学术

Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study

Published:2021-01 Issue:1 Volume:8 Page:e33-e41
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Pereira Gerson Fernando Mendes,Kim Ahra,Jalil Emilia M,Fernandes Fonseca Fernanda,Shepherd Bryan E,Veloso Valdilea G,Rick Fernanda,Ribeiro Rachel,Pimenta Maria Cristina,Beber Andrea,Corrêa Renato Girade,Lima Renato,Maruri Fernanda,McGowan Catherine C,Schwartz Benzaken Adele,Grinsztejn Beatriz,Castilho Jessica L

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference24 articles.

1. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach—2nd edn. 2016,2016

2. Neural-tube defects with dolutegravir treatment from the time of conception;Zash;N Engl J Med,2018

3. Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study;Joao;J Acquir Immune Defic Syndr,2010

4. Antiretroviral combination use during pregnancy and the risk of major congenital malformations;Berard;AIDS,2017

5. Surveillance monitoring for safety of in utero antiretroviral therapy exposures: current strategies and challenges;Zash;Expert Opin Drug Saf,2016

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The safety of a dolutegravir (DTG)-based antiretroviral treatment (ART) regimen for pregnancy and birth outcomes in Ethiopia: evidence from multicenter cohort study;BMC Infectious Diseases;2024-09-02

2. Experiencia de la cohorte nacional de mujeres embarazadas que viven con VIH y sus hijos en España: evolución de la transmisión materno-infantil de VIH e infecciones asociadas;Anales de Pediatría;2024-08

3. “No One Needs to be Forced”: Qualitative Insights on Competing Priorities between Antiretroviral Therapy and Reproductive Health Planning during the Dolutegravir Rollout;AIDS and Behavior;2024-07-31

4. Integrase inhibitor drugs during pregnancy and congenital anomalies: A case/non‐case study from the global pharmacovigilance database VigiBase®;Pharmacology Research & Perspectives;2024-07-31

5. Challenges for Novel Antiretroviral Development in an Era of Widespread tenofovir-disoproxil/lamivudine (or emtricitabine)/dolutegravir availability (TLD) Availability;Clinical Infectious Diseases;2024-07-11